Evidence map›Paper›PMID 31748578›Full record

ArticleScientific reports2019

Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice.

Jerel Adam Fields, Mary K Swinton, Aliyah Carson, Benchawanna Soontornniyomkij, Charmaine Lindsay, May Madi Han, Katie Frizzi, Shrey Sambhwani, Anne Murphy, Cristian L Achim and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Tenofovir disoproxil fumarate mediates neuronal injury by inducing neurotoxicity.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. The Potential ofCells · 2022
    Review
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jerel Adam FieldsDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA. jafields@ucsd.edu.
Mary K SwintonDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Aliyah CarsonDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Benchawanna SoontornniyomkijDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
Charmaine LindsayDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
May Madi HanDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
Katie FrizziDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
Shrey SambhwaniDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Anne MurphyDepartment of Pharmacology, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-5222-9902
Cristian L AchimDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
Ronald J EllisDepartment of Neurosciences, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-4931-752X
Nigel A CalcuttDepartment of Pathology, University of California San Diego, La Jolla, CA, USA.
University of California San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
Cholinergic constraint and diabetic neuropathyR01NS081082 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CALCUTT, NIGEL A. · 2013 to 2017
$1.6M
Mitochondrial biogenesis dysfunction in the CNS of HIV-infected individuals on antiretroviral therapyK01MH115819 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIELDS, JEREL ADAM · 2018 to 2020
$480k
Development of Pirenzepine for HIV-SNR41NS105177 · NINDS · WINSANTOR, INC. · PI FIELDS, JEREL ADAM, MIZISIN, ANDREW · 2017 to 2017
$466k
NIDA NIH HHS P50 DA026306NIMHD NIH HHS L60 MD013161NIMH NIH HHS K01 MH115819NIMH NIH HHS P30 MH062512NINDS NIH HHS R01 NS081082NINDS NIH HHS R41 NS105177
6 · The paper itself

Abstract

Mounting evidence suggests that antiretroviral therapy (ART) drugs may contribute to the prevalence of HIV-associated neurological dysfunction. The HIV envelope glycoprotein (gp120) is neurotoxic and has been linked to alterations in mitochondrial function and increased inflammatory gene expression, which are common neuropathological findings in HIV+ cases on ART with neurological disorders. Tenofovir disproxil fumarate (TDF) has been shown to affect neurogenesis in brains of mice and mitochondria in neurons. In this study, we hypothesized that TDF contributes to neurotoxicity by modulating mitochondrial biogenesis and inflammatory pathways. TDF administered to wild-type (wt) and GFAP-gp120 transgenic (tg) mice caused peripheral neuropathy, as indicated by nerve conduction slowing and thermal hyperalgesia. Conversely TDF protected gp120-tg mice from cognitive dysfunction. In the brains of wt and gp120-tg mice, TDF decreased expression of mitochondrial transcription factor A (TFAM). However, double immunolabelling revealed that TFAM was reduced in neurons and increased in astroglia in the hippocampi of TDF-treated wt and gp120-tg mice. TDF also increased expression of GFAP and decreased expression of IBA1 in the wt and gp120-tg mice. TDF increased tumor necrosis factor (TNF) α in wt mice. However, TDF reduced interleukin (IL) 1β and TNFα mRNA in gp120-tg mouse brains. Primary human astroglia were exposed to increasing doses of TDF for 24 hours and then analyzed for mitochondrial alterations and inflammatory gene expression. In astroglia, TDF caused a dose-dependent increase in oxygen consumption rate, extracellular acidification rate and spare respiratory capacity, changes consistent with increased metabolism. TDF also reduced IL-1β-mediated increases in IL-1β and TNFα mRNA. These data demonstrate that TDF causes peripheral neuropathy in mice and alterations in inflammatory signaling and mitochondrial activity in the brain.

Indexed as

AnimalsAnti-HIV AgentsBrainCell LineDisease Models, AnimalGene ExpressionHumansInflammationMiceMice, TransgenicMitochondriaNeuronsOrganelle BiogenesisPeripheral Nervous System DiseasesSignal TransductionTenofovirAnti-HIV AgentsTenofovir

Identifiers

PMID31748578
PMCPMC6868155
OpenAlexW2990895553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.